Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

Goodwin GM; Consensus Group of the British Association for Psychopharmacology.

J Psychopharmacol. 2009 Jun;23(4):346-88. doi: 10.1177/0269881109102919. Epub 2009 Mar 27.

PMID:
19329543
3.

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.

Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A.

J Psychopharmacol. 2008 Jun;22(4):343-96. doi: 10.1177/0269881107088441. Epub 2008 Apr 15.

PMID:
18413657
4.

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.

Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU; British Association for Psychopharmacology.

J Psychopharmacol. 2005 Nov;19(6):567-96.

PMID:
16272179
5.

[Methodological approach to inter "guideline" variability in the management of bipolar disorders].

Samalin L, Llorca PM.

Encephale. 2012 Apr;38(2):126-32. doi: 10.1016/j.encep.2011.07.004. Epub 2011 Aug 31. Review. French.

PMID:
22516270
6.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.

Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R, Singh AB.

Aust N Z J Psychiatry. 2015 Dec;49(12):1087-206. doi: 10.1177/0004867415617657. Review.

7.

Controversies in the psychopharmacology of bipolar disorder.

Post RM, Ostacher MJ, Singh V.

J Clin Psychiatry. 2014 Nov;75(11):e30. doi: 10.4088/JCP.13095tx2cj. Review.

8.

Assessment and treatment of bipolar II postpartum depression: a review.

Sharma V, Burt VK, Ritchie HL.

J Affect Disord. 2010 Sep;125(1-3):18-26. doi: 10.1016/j.jad.2009.09.014. Epub 2009 Oct 17. Review.

PMID:
19837461
9.

[Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].

Geoffroy PA, Bellivier F, Henry C.

Encephale. 2014 Sep;40(4):330-7. doi: 10.1016/j.encep.2013.10.007. Epub 2014 Feb 7. Review. French.

10.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

11.

Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?

Samalin L, Guillaume S, Courtet P, Abbar M, Lancrenon S, Llorca PM.

Compr Psychiatry. 2013 May;54(4):309-20. doi: 10.1016/j.comppsych.2012.10.001. Epub 2012 Nov 13. Review.

PMID:
23153855
12.

Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012.

Kanba S, Kato T, Terao T, Yamada K; Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders, 2012.

Psychiatry Clin Neurosci. 2013 Jul;67(5):285-300. doi: 10.1111/pcn.12060. Epub 2013 Jun 18. Review.

13.

Bipolar disorder.

Keck PE Jr, McElroy SL, Arnold LM.

Med Clin North Am. 2001 May;85(3):645-61, ix. Review.

PMID:
11349478
14.

Decision tree for the treatment of bipolar disorder.

Sachs GS.

J Clin Psychiatry. 2003;64 Suppl 8:35-40. Review.

15.

International Consensus Group on Bipolar I Depression Treatment Guidelines.

Calabrese JR, Kasper S, Johnson G, Tajima O, Vieta E, Yatham LN, Young AH.

J Clin Psychiatry. 2004 Apr;65(4):571-9. Review. No abstract available.

PMID:
15119923
16.

[Psychopharmacotherapy of bipolar affective diseases].

Grunze H, Walden J, Dittmann S, Berger M, Bergmann A, Bräunig P, Dose M, Emrich HM, Gastpar M, Greil W, Krüger S, Möller HJ, Uebelhack R.

Nervenarzt. 2002 Jan;73(1):4-17; quiz 18-9. Review. German.

PMID:
11975062
17.

Medication treatment of bipolar disorder in developmentally disabled children and adolescents.

Gutkovich ZA, Carlson GA.

Minerva Pediatr. 2008 Feb;60(1):69-85. Review.

PMID:
18277367
18.

Challenges in the diagnosis & treatment of bipolar depression--part 2: treatment options.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2006 May;44(5):9-12. Review. No abstract available.

PMID:
16719182
19.

Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.

Hamrin V, McDonnell MA, Moffett J, Durso S.

Minerva Pediatr. 2008 Feb;60(1):87-101. Review.

PMID:
18277368
20.

Pediatric bipolar disorder: evidence-based psychopharmacological treatments.

Hamrin V, Pachler M.

J Child Adolesc Psychiatr Nurs. 2007 Feb;20(1):40-58. Review.

PMID:
17284237

Supplemental Content

Support Center